blood clots and semaglutide Wegovy Clots: Do GLP-1 Drugs Increase Your Risk of DVT and PE? Semaglutide (#ozempic / #wegovy) increased

A separate recent (2024) law review article that examined recent court cases also found that: There have been no examples of patent infringement lawsuits brought by drug manufacturers against compounding pharmacies that have reached trial or substantive judgments by courts. Most litigation against pharmacies compounding semaglutide during the shortage has focused on trademark law and unfair competition, the latter of which has included claims for deceptive business practices under state law and for false advertising under the Lanham Act (15 U.S.C

Would a lower maintenance dose make more sense

Due to the complexity of NASH, no current treatment is approved for it (126) and most therapies remain to be traditional and focus on lifestyle intervention, which is difficult to maintain (127)

10.3390/nu15102264

In general, this is a safe and accepted practice when a doctor is the one prescribing or recommending off-label usage